Advanced search
Publication Cover
Cancer Management and Research Volume 9, 2017 - Issue
Submit an article Journal homepage
152
Views
3
CrossRef citations to date
0
Altmetric
Review

Can biosimilars help achieve the goals of US health care reform?

Ralph Boccia1 Center for Cancers and Blood Disorders, Bethesda, MD
,
Ira Jacobs2 Global Medical Affairs, Pfizer Inc., New York, NYCorrespondence[email protected]
,
Robert Popovian3 US Government Relations, Pfizer Inc., Washington, DC
&
Gilberto de Lima Lopes Jr4 Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
Pages 197-205 | Published online: 01 Jun 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Gabriel Horta-Baas. (2022) Patient-Reported Outcomes in Rheumatoid Arthritis: A Key Consideration for Evaluating Biosimilar Uptake?. Patient Related Outcome Measures 13, pages 79-95.
Read now
Kashyap B Patel, Luiz H Arantes$suffix/text()$suffix/text(), Wing Yu Tang & Selwyn Fung. (2018) The role of biosimilars in value-based oncology care. Cancer Management and Research 10, pages 4591-4602.
Read now
Akram Hernández-Vásquez, Christoper A. Alarcon-Ruiz, Guido Bendezu-Quispe, Daniel Comandé & Diego Rosselli. (2018) A bibliometric analysis of the global research on biosimilars. Journal of Pharmaceutical Policy and Practice 11:1.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.